Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.64M | 1.64M | 1.54M | 1.42M | 1.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.64M | 1.64M | 1.54M | 1.42M | 1.33M |
| Cost of Revenue | 1.40M | 1.45M | 1.43M | 1.29M | 1.17M |
| Gross Profit | 240.50K | 187.40K | 113.70K | 132.40K | 156.00K |
| SG&A Expenses | 2.90M | 3.83M | 4.82M | 5.04M | 4.90M |
| Depreciation & Amortization | 270.60K | 356.20K | 441.30K | 424.20K | 309.50K |
| Other Operating Expenses | 3.00K | 3.00K | 3.00K | 3.80K | 3.90K |
| Total Operating Expenses | 4.58M | 5.71M | 6.77M | 6.84M | 6.55M |
| Operating Income | -2.94M | -4.07M | -5.22M | -5.41M | -5.22M |
| Income Before Tax | -7.24M | -8.17M | -9.76M | -9.92M | -9.57M |
| Income Tax Expenses | -107.90K | -107.90K | -107.90K | -107.90K | -35.70K |
| Earnings from Continuing Operations | -7.13 | -8.06 | -9.65 | -9.82 | -9.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.13M | -8.06M | -9.65M | -9.82M | -9.53M |
| EBIT | -2.94M | -4.07M | -5.22M | -5.41M | -5.22M |
| EBITDA | -2.73M | -3.75M | -4.80M | -5.00M | -4.91M |
| EPS Basic | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 1.04B | 1.02B | 978.56M | 913.43M | 859.79M |
| Average Diluted Shares Outstanding | 1.04B | 1.02B | 978.56M | 913.43M | 859.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
